Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease
OBJECTIVES:
I. Assess the efficacy and safety of 4-aminosalicylic acid in patients with active Crohn's disease of the small bowel.
研究概览
详细说明
PROTOCOL OUTLINE: This is a randomized, placebo controlled, multicenter study. Patients are randomized to receive either oral 4-aminosalicylic acid (4-ASA) or placebo twice a day for 12 weeks. After 12 weeks patients who improved with 4-ASA and those who received placebo are given the option of receiving 4-ASA for an additional year.
Patients who were randomized to receive 4-ASA and continue treatment after 12 weeks are followed every 3 months for 1 year. Patients who were randomized to receive placebo and begin 4-ASA therapy after 12 weeks are followed monthly for 3 months, then every 3 months for 1 year.
Completion date provided represents the completion date of the grant per OOPD records
研究类型
注册
阶段
- 不适用
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
- Active small bowel Crohn's disease established by clinical evaluation and prior radiologic study, endoscopy, surgical findings and/or histopathology
- Crohn's Disease Activity Index (CDAI) must be between 150 and 450
- No ulcerative or infectious colitis or severe perianal disease
--Prior/Concurrent Therapy--
- Biologic therapy: Not specified
- Chemotherapy: Stable dose of no greater than 20 mg per day of prednisone allowed
- Endocrine therapy: No immunosuppressive drugs within the past 3 months No concurrent immunosuppressive drugs
- Radiotherapy: Not specified
- Surgery: No impending surgery No prior ileostomy or colostomy
- Other: No 5-aminosalicylates within the past 2 weeks No concurrent 5-aminosalicylates No concurrent metronidazol or ciprofloxacin
--Patient Characteristics--
- Age: 18 to 80
- Performance status: Ambulatory
- Hematopoietic: Not specified
- Hepatic: No hepatic disease
- Renal: No renal disease
- Other: Not pregnant (negative pregnancy test required) Fertile patients must use effective contraception No documented salicylate allergy
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
合作者和调查者
调查人员
- 学习椅:James A. Vecchio、University of Vermont
研究记录日期
研究主要日期
学习开始
研究完成
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
-aminosalicylic acid的临床试验
-
University College, LondonImperial College London; Cancer Research UK; National Cancer Imaging Translational Accelerator招聘中
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)招聘中
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI); Complexa, Inc.终止
-
Critical Outcome Technologies Inc.M.D. Anderson Cancer Center; Northwestern Memorial Hospital未知宫颈癌 | 头颈癌 | 大肠癌 | 胰腺癌 | 卵巢癌 | 输卵管癌 | 肺癌 | 子宫内膜癌 | 腹膜癌 | HNSCC美国